Vor Biopharma VOR
NASDAQ VOR
$18.69 +0.63 (+3.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vor Biopharma (VOR) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Vor Biopharma (VOR) reported Return on Capital Employed [ROCE] of -31.35% for Q2 2026, up 341.38 percentage points from -372.73% a year earlier and up 48.22 percentage points from the prior quarter.

Analysis

Vor Biopharma (VOR) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Vor Biopharma posted Return on Capital Employed [ROCE] of -133.52%, down 53.74 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for three consecutive years, with a four-year change of -87.23 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -79.78% in FY2024 (-25.73 pp), -54.05% in FY2023 (-17.82 pp), -36.23% in FY2022 (+10.06 pp) and -46.29% in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q4 2021.
  • Year over year, Return on Capital Employed [ROCE] gained in two of the last eight quarters, with an average year-over-year change of -20.75 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2026 (a gain of 341.38 percentage points); the low point was Q2 2025 (a drop of 283.91 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -79.58% (Q1 2026), -125.98% (Q4 2025) and -213.41% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Vor Biopharma 1.02 Bn 1.02 Bn - -31.35%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -31.35%
Mar 31, 2026 -79.58%
Dec 31, 2025 -125.98%
Sep 30, 2025 -213.41%
Jun 30, 2025 -372.73%
Mar 31, 2025 -111.68%
Dec 31, 2024 -109.34%
Sep 30, 2024 -103.10%
Jun 30, 2024 -88.82%
Mar 31, 2024 -75.54%
Dec 31, 2023 -64.63%
Sep 30, 2023 -55.34%
Jun 30, 2023 -44.30%
Mar 31, 2023 -36.63%
Dec 31, 2022 -38.96%
Sep 30, 2022 -42.56%
Jun 30, 2022 -37.53%
Mar 31, 2022 -35.45%
Dec 31, 2021 -28.70%
Sep 30, 2021 -25.76%
API Access

Vor Biopharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VOR&period=max&api_key=YOUR_API_KEY